Immunogenic adverse events to CFTR modulators - An international survey (2025)
Attributed to:
A personalised approach to manage adverse reactions to CFTR modulator therapy in patients with cystic fibrosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcf.2025.03.003
Publication URI: http://dx.doi.org/10.1016/j.jcf.2025.03.003
Type: Journal Article/Review
Parent Publication: Journal of Cystic Fibrosis
Issue: 3